Susquehanna International Group’s Trillium Therapeutics Inc. TRIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-379,627
| Closed | -$6.67M | – | 6816 |
|
|
2021
Q3 | $6.67M | Buy |
379,627
+277,635
| +272% | +$4.88M | ﹤0.01% | 994 |
|
|
2021
Q2 | $989K | Sell |
101,992
-81,309
| -44% | -$788K | ﹤0.01% | 2990 |
|
|
2021
Q1 | $1.97M | Sell |
183,301
-180,805
| -50% | -$1.94M | ﹤0.01% | 2137 |
|
|
2020
Q4 | $5.36M | Sell |
364,106
-9,914
| -3% | -$146K | ﹤0.01% | 959 |
|
|
2020
Q3 | $5.32M | Buy |
374,020
+69,704
| +23% | +$991K | ﹤0.01% | 804 |
|
|
2020
Q2 | $2.46M | Buy |
304,316
+193,430
| +174% | +$1.56M | ﹤0.01% | 1284 |
|
|
2020
Q1 | $448K | Buy |
+110,886
| New | +$448K | ﹤0.01% | 2995 |
|
|
2019
Q2 | – | Sell |
-98,673
| Closed | -$65K | – | 5228 |
|
|
2019
Q1 | $65K | Buy |
+98,673
| New | +$65K | ﹤0.01% | 2744 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 5082 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 4892 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 4787 |
|
|
2016
Q4 | – | Sell |
-25,170
| Closed | -$372K | – | 4951 |
|
|
2016
Q3 | $372K | Buy |
+25,170
| New | +$372K | ﹤0.01% | 2168 |
|